Next Article in Journal
Lower Limb Amputation Rates in Germany
Previous Article in Journal
Process Evaluation of Lumbar Interbody Fusion Surgeries in Five Dutch Hospitals: A Qualitative Analysis
Previous Article in Special Issue
BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC
Review

Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions

1
Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
2
Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
3
Department of Medication Education, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
4
The Wright Center for Graduate Medical Education, Scranton, PA 18501, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Antonio M Scanu and Maria Rosaria De Miglio
Medicina 2022, 58(1), 100; https://doi.org/10.3390/medicina58010100
Received: 18 December 2021 / Revised: 30 December 2021 / Accepted: 4 January 2022 / Published: 10 January 2022
(This article belongs to the Special Issue Therapeutic Landscapes in Colorectal Carcinoma)
The coronavirus disease 2019 (COVID-19) pandemic has brought significant challenges to many aspects of healthcare delivery since the first reported case in early December 2019. Once in the body, SARS-CoV-2 can spread to other digestive organs, such as the liver, because of the presence of ACE2 receptors. Colorectal cancer (CRC) remains the second-leading cause of death in the United States (US). Therefore, individuals are routinely screened using either endoscopic methods (i.e., flexible sigmoidoscopy and colonoscopy) or stool-based tests, as per the published guidelines. At the beginning of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services (CMS) recommended that all non-urgent surgical and medical procedures, including screening colonoscopies, be delayed until the pandemic stabilization. This article aims to review the impact of COVID-19 on CRC screening. View Full-Text
Keywords: colorectal cancer screening; COVID-19; SARS-CoV-2 colorectal cancer screening; COVID-19; SARS-CoV-2
Show Figures

Figure 1

MDPI and ACS Style

Kopel, J.; Ristic, B.; Brower, G.L.; Goyal, H. Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions. Medicina 2022, 58, 100. https://doi.org/10.3390/medicina58010100

AMA Style

Kopel J, Ristic B, Brower GL, Goyal H. Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions. Medicina. 2022; 58(1):100. https://doi.org/10.3390/medicina58010100

Chicago/Turabian Style

Kopel, Jonathan, Bojana Ristic, Gregory L. Brower, and Hemant Goyal. 2022. "Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions" Medicina 58, no. 1: 100. https://doi.org/10.3390/medicina58010100

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop